Henry Schein Profile

USD 1.54  1.77%

Exercise or conversion by Mark Mlotek of 19875 shares of Henry Schein subject to Rule 16b-3

Henry Schein insider trading alert for exercise of stock option (right to buy) by Mark Mlotek, EVP of Corp. Bus. Devel., on October 18, 2018. This event was filed by Henry Schein Inc with SEC on 2007-05-21. Statement of changes in beneficial ownership - SEC Form 4. Mark Mlotek is currently serves as chief strategic officer, executive vp and director of Henry Schein [view details]   

Henry Schein Summary

Henry Schein (HSIC) is traded on BATS Exchange in USA. It is located in New York U.S.A and employs 22,000 people. Henry Schein is listed under Wholesale category by Fama And French industry classification.The company currently falls under 'Large-Cap' category with current market capitalization of 13.08 B. Henry Schein conducts business under Healthcare sector and is part of Medical Distribution industry. This company has 153.11 M outstanding shares of which 16.63 M shares are currently shorted by private and institutional investors with about 11.38 trading days to cover. HENRY SCHEIN INC currently holds about 111.32 M in cash with 451.63 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.73.
Check Henry Schein Probability Of Bankruptcy

Ownership Allocation (%)

Henry Schein Target Price Odds Analysis

Odds Below 85.43HorizonTargetOdds Above 85.43
81.71%30 days 85.43 18.00%
Based on normal probability distribution, the odds of Henry Schein to move above current price in 30 days from now is about 18.0% (This Henry Schein probability density function shows the probability of Henry Schein Stock to fall within a particular range of prices over 30 days) .

Henry Schein Top Holders

Henry Schein Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Longview Partners Guernsey LtdCommon Shares13.7 M1.2 B
Blackrock IncCommon Shares10.6 M903.9 M
View Henry Schein Diagnostics

Henry Schein Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Henry Schein Key Fundamentals

Henry Schein Against Markets

Henry Schein Current Ratings

Henry Schein 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Henry Schein are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. The company was founded in 1932 and is headquartered in Melville, New York. Henry Schein operates under Medical Distribution classification in USA and is traded on BATS Exchange. It employs 22000 people. more
Fama & French Wholesale
Fama & French Classification
Henry Schein SEC Filings
Henry Schein SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameHenry Schein
CEOLonnie ShoffView All
Thematic Classifications
Active Investing Ideas
showing 2 out of 3 themes  View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Healthcare, Medical Distribution
InstrumentUSA Stock View All
RegionNorth America
LocationNew York U.S.A
Business Address135 Duryea Road
Foreign Associate  Austria
ExchangeBATS Exchange
CIK Number0001000228
IndustryMedical Distribution
Phone631 843 5500
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 30, 2019
Most Recent QuarterJune 30, 2018
Last Fiscal Year EndDecember 30, 2017
Date Short InterestOctober 15, 2018

Henry Schein Directors

Henry Schein Corporate Directors

Norman Matthews Independent Director
Philip Laskawy Lead Independent Director
Steven Paladino CFO, Executive VP and Executive Director
Please also check Risk vs Return Analysis. Please also try Money Flow Index module to determine momentum by analyzing money flow index and other technical indicators.
Search macroaxis.com